O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.39%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.3B
AUM Growth
+$10.3B
(+13%)
Cap. Flow
+$348M
Cap. Flow
% of AUM
3.38%
Top 10 Holdings %
Top 10 Hldgs %
36.86%
Holding
137
New
10
Increased
53
Reduced
17
Closed
11
Top Buys
| 1 |
Biogen
BIIB
|
$103M |
| 2 |
SIEN
Sientra, Inc.
SIEN
|
$53.5M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$49.5M |
| 4 |
MGLN
Magellan Health Services, Inc.
MGLN
|
$48.3M |
| 5 |
Gilead Sciences
GILD
|
$45.9M |
Top Sells
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
$215M |
| 2 |
Arrowhead Research
ARWR
|
$76.5M |
| 3 |
STJ
St Jude Medical
STJ
|
$55.3M |
| 4 |
QGENF
QIAGEN NV
QGENF
|
$38.7M |
| 5 |
OraSure Technologies
OSUR
|
$34.4M |
Sector Composition
| 1 | Healthcare | 87.22% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Xencor
XNCR
$580M
| $16.8M | 0.16% | 1,046,000 +207,300 | +25% | +$3.33M |
|
|
MRGE
77
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $16.5M | 0.16% | 4,628,500 | – | – |
|
78
Pacira BioSciences
PCRX
$1.2B
| $15.6M | 0.15% | 176,000 -61,900 | -26% | -$5.49M |
|
|
SAGE
79
DELISTED
Sage Therapeutics
SAGE
| $15.1M | 0.14% | 412,335 -125,000 | -23% | -$4.57M |
|
|
SVA
80
DELISTED
Sinovac Biotech, Ltd
SVA
| $14.8M | 0.14% | 2,821,500 | – | – |
|
|
ROKA
81
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $14.2M | 0.14% | 3,220,429 | – | – |
|
|
HZNP
82
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.9M | 0.13% | 1,075,000 +179,000 | +20% | +$2.31M |
|
|
STJ
83
DELISTED
St Jude Medical
STJ
| $11.3M | 0.11% | 173,000 -850,600 | -83% | -$55.3M |
|
84
MEI Pharma
MEIP
$160M
| $10.4M | 0.1% | 2,424,500 +500,000 | +26% | +$2.14M |
|
|
PTX
85
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $10.1M | 0.1% | 1,073,000 | – | – |
|
|
AGEN
86
Agenus
AGEN
$133M
| $9.69M | 0.09% | 2,441,500 -1,144,600 | -32% | -$4.54M |
|
87
MiMedx Group
MDXG
$1.05B
| $9.65M | 0.09% | 836,800 +41,400 | +5% | +$477K |
|
88
Abbott
ABT
$231B
| $9.5M | 0.09% | 211,000 +31,000 | +17% | +$1.4M |
|
|
SLXP
89
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $9.43M | 0.09% | 82,000 | – | – |
|
|
AET
90
DELISTED
Aetna Inc
AET
| $8.35M | 0.08% | 94,000 +14,000 | +18% | +$1.24M |
|
|
ALIM
91
DELISTED
Alimera Sciences, Inc.
ALIM
| $8.31M | 0.08% | 1,500,000 | – | – |
|
|
RDHL
92
Redhill Biopharma
RDHL
$3.1M
| $8.08M | 0.08% | 605,800 | – | – |
|
|
GEVA
93
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $7.22M | 0.07% | 77,800 -33,300 | -30% | -$3.09M |
|
94
Xoma
XOMA
$392M
| $7.18M | 0.07% | 2,000,000 -437,000 | -18% | -$1.57M |
|
|
ARQL
95
DELISTED
Arqule Inc
ARQL
| $6.96M | 0.07% | 5,702,000 | – | – |
|
|
RGLS
96
DELISTED
Regulus Therapeutics
RGLS
| $6.42M | 0.06% | +400,000 | New | +$6.42M |
|
97
DaVita
DVA
$9.85B
| $5.76M | 0.06% | 76,000 +11,000 | +17% | +$833K |
|
|
ASPX
98
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $4.91M | 0.05% | +93,600 | New | +$4.91M |
|
99
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.81M | 0.05% | 580,000 | – | – |
|
100
Boston Scientific
BSX
$156B
| $4.24M | 0.04% | 320,000 +48,300 | +18% | +$640K |
|